Literature DB >> 11322251

Foscarnet-induced changes in plasma concentrations of total and ionized calcium and magnesium in HIV-positive patients.

F H Noormohamed1, M S Youle, B Tang, S Martin-Munley, B G Gazzard, A F Lant.   

Abstract

The time course and magnitude of foscarnet-induced changes in plasma concentrations of total and ionized calcium and magnesium were investigated in 13 male HIV-positive patients who had no active cytomegalovirus-associated disease. The patients had a mean age of 36 years (range 25-49 years) and a mean CD4 cell count of 550 cells/mm3 (range 130-1280 cells/mm3). Peak (mean +/- SD) plasma concentrations of foscarnet (0.89+/-0.10 mmol/l) were seen at the end of the period of drug infusion (90 mg/kg of foscarnet was infused over 2 hours) and declined with a terminal half-life of 5.7+/-0.7 hours. Plasma concentrations of total calcium declined over an 8-hour period, with the lowest concentration occurring after 4 hours (baseline: 2.29+/-0.09 mmol/l; lowest: 2.18+/-0.07 mmol/l; P < 0.001). By contrast, the lowest plasma concentration of ionized calcium occurred after 2 hours (baseline: 1.25+/-0.04 mmol/l; lowest: 0.99+/-0.05 mmol/l; P < 0.001), before gradually recovering to baseline levels over the next 10 hours. The mean maximal decrease in total calcium was 0.11+/-0.06 mmol/l, compared with 0.26+/-0.04 mmol/l for ionized calcium (P < 0.001). Plasma concentrations of total magnesium declined from 0.79+/-0.06 mmol/l (baseline) to 0.74+/-0.04 mmol/l (P < 0.05) after 4 hours and remained at this level after 8 hours. However, plasma concentrations of ionized magnesium fell steeply from 0.56+/-0.03 mmol/l to 0.39+/-0.03 mmol/l at 2 hours (P < 0.001), followed by a gradual recovery over the next 10 hours. The mean maximal decrease in total magnesium was 0.05+/-0.08 mmol/l, compared with 0.18+/-0.03 mmol/l (P < 0.001) for ionized magnesium. In summary, we found that foscarnet-induced changes in the plasma concentrations of total calcium and magnesium were dissociated from the corresponding changes in ionized calcium and magnesium. The maximal decreases in the plasma concentrations of total calcium and magnesium were smaller in magnitude and occurred much later than did the changes in ionized calcium and magnesium. The relative changes in the plasma concentration of ionized magnesium were greater than those of ionized calcium, indicating that foscarnet binds preferentially to the magnesium ion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 11322251

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  6 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Pharmacokinetics and absolute bioavailability of oral foscarnet in human immunodeficiency virus-seropositive patients.

Authors:  F H Noormohamed; M S Youle; C J Higgs; S Martin-Munley; B G Gazzard; A F Lant
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

3.  A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection.

Authors:  M M Huycke; M T Naguib; M M Stroemmel; K Blick; K Monti; S Martin-Munley; C Kaufman
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 4.  Minimising the dosage-limiting toxicities of foscarnet induction therapy.

Authors:  D T Jayaweera
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

Review 5.  Hypomagnesemia in the Cancer Patient.

Authors:  Biruh T Workeneh; Nupur N Uppal; Kenar D Jhaveri; Helbert Rondon-Berrios
Journal:  Kidney360       Date:  2020-11-11

6.  Magnesium metabolism and its disorders.

Authors:  R Swaminathan
Journal:  Clin Biochem Rev       Date:  2003-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.